176 related articles for article (PubMed ID: 17227110)
1. Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease.
Tampoia M; Brescia V; Fontana A; Zucano A; Morrone LF; Pansini N
Arch Pathol Lab Med; 2007 Jan; 131(1):112-6. PubMed ID: 17227110
[TBL] [Abstract][Full Text] [Related]
2. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
[TBL] [Abstract][Full Text] [Related]
3. Harmonization of autoimmune diagnostics with antinuclear antibody testing algorithm: approach of appropriateness and clinical relevance.
Melegari A; Bonaguri C
Isr Med Assoc J; 2014 Oct; 16(10):640-2. PubMed ID: 25438456
[No Abstract] [Full Text] [Related]
4. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.
Bossuyt X; De Langhe E; Borghi MO; Meroni PL
Nat Rev Rheumatol; 2020 Dec; 16(12):715-726. PubMed ID: 33154583
[TBL] [Abstract][Full Text] [Related]
5. Antinuclear antibody titer and antibodies to extractable nuclear antigens.
Bossuyt X; Hendrickx A; Frans J
Arthritis Rheum; 2005 Dec; 53(6):987-8. PubMed ID: 16342092
[No Abstract] [Full Text] [Related]
6. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
7. The dense fine speckled antinuclear antibody pattern in autoimmune rheumatic disease: comment on the article by Mariz et al.
Craig WY; Ledue TB
Arthritis Rheum; 2011 Jun; 63(6):1759; author reply 1760. PubMed ID: 21425126
[No Abstract] [Full Text] [Related]
8. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases.
Tozzoli R; Bizzaro N; Tonutti E; Villalta D; Bassetti D; Manoni F; Piazza A; Pradella M; Rizzotti P;
Am J Clin Pathol; 2002 Feb; 117(2):316-24. PubMed ID: 11863229
[TBL] [Abstract][Full Text] [Related]
9. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
[TBL] [Abstract][Full Text] [Related]
10. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases.
Bizzaro N; Brusca I; Previtali G; Alessio MG; Daves M; Platzgummer S; Cinquanta L; Paura G; Infantino M; Manfredi M; Faricelli R; Bassetti D; Musso M; Deleonardi G; Trevisan MT; Radice A; Liguori M; Imbastaro T; Pesente F; Fabris M; Tonutti E
Autoimmun Rev; 2018 Jun; 17(6):541-547. PubMed ID: 29631063
[No Abstract] [Full Text] [Related]
11. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
12. Detection of anti-nuclear antibodies by indirect immunofluorescence on HEp-2 cells: setting the appropriate screening dilution for the diagnosis of autoimmune rheumatic diseases.
Brito Fde A; Santos SM; Ferreira GA; Pedrosa W; Gradisse J; Costa LC; Neves SP
Rev Bras Reumatol; 2014; 54(1):13-20. PubMed ID: 24878786
[TBL] [Abstract][Full Text] [Related]
13. Mortality in autoimmune rheumatic diseases with anti-Ro/SSA antibody in Korea: Single center-based retrospective study.
Kim SK; Choe JY; Kwak SG
Int J Rheum Dis; 2019 Feb; 22(2):191-199. PubMed ID: 30398019
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances in immunologic laboratory testing for rheumatic diseases].
Akahoshi T
Rinsho Byori; 2004 Sep; 52(9):743-50. PubMed ID: 15552934
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.
Solomon DH; Kavanaugh AJ; Schur PH;
Arthritis Rheum; 2002 Aug; 47(4):434-44. PubMed ID: 12209492
[No Abstract] [Full Text] [Related]
17. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to hnRNPs in patients with a systemic rheumatic disease with no antibodies to extractable nuclear antigens or dsDNA.
De Beéck KO; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Rheumatology (Oxford); 2012 Aug; 51(8):1515-6. PubMed ID: 22661555
[No Abstract] [Full Text] [Related]
19. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
[TBL] [Abstract][Full Text] [Related]
20. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
Breda L; Nozzi M; De Sanctis S; Chiarelli F
Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
